Cargando…

Increases in GFAP immunoreactive astrocytes in the cerebellar molecular layer of young adult CBA/J mice

BACKGROUND: CBA/J mice are standard experimental animals in auditory studies, and age-related changes in auditory pathways are well documented. However, changes in locomotion-related brain regions have not been systematically explored. RESULTS: We showed an increase in immunoreactivity for glial fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyszkiewicz, Cheryl, Pardo, Ingrid D, Ritenour, Hayley N, Liu, Chang-Ning, Somps, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400896/
https://www.ncbi.nlm.nih.gov/pubmed/34454633
http://dx.doi.org/10.1186/s42826-021-00100-5
Descripción
Sumario:BACKGROUND: CBA/J mice are standard experimental animals in auditory studies, and age-related changes in auditory pathways are well documented. However, changes in locomotion-related brain regions have not been systematically explored. RESULTS: We showed an increase in immunoreactivity for glial fibrillary acidic protein (GFAP) in the cerebellar molecular layer associated with Purkinje cells in mice at 24 weeks of age but not in the younger mice. Increased GFAP immunoreactivity appeared in the form of clusters and distributed multifocally consistent with hyperplasia of astrocytes that were occasionally associated with Purkinje cell degeneration. Three out of 12 animals at 16 and 24 weeks of age exhibited pre-convulsive clinical signs. Two of these 3 animals also showed increased GFAP immunoreactivity in the cerebellum. Rotarod behavioral assessments indicated decreased performance at 24 weeks of age. CONCLUSIONS: These results suggest minimal to mild reactive astrocytosis likely associated with Purkinje cell degeneration in the cerebellum at 24 weeks of age in CBA/J mice. These findings should be taken into consideration prior to using this mouse strain for studying neuroinflammation or aging. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42826-021-00100-5.